Pre-birth origins of allergy and asthma

K L Gatford1, A L Wooldridge2, K L Kind3

  • 1Robinson Research Institute, Australia; Adelaide Medical School, Australia.

Insights

Early life factors significantly influence allergy development. Experimental models show that a restricted fetal environment, like intrauterine growth restriction (IUGR), can alter immune responses, but methyl donor supplementation may offer protection.

Area of Science:

  • Immunology
  • Developmental Biology
  • Perinatal Medicine

Background:

  • Allergy is a chronic disease influenced by early life factors.
  • Associations between birth size and allergy are complex and confounded in human studies.
  • Experimental models are crucial for investigating the impact of the prenatal environment on allergy.

Purpose of the Study:

  • To investigate how a restricted prenatal environment affects allergy development using ovine models.
  • To explore the role of methyl donor availability in protecting against allergy in intrauterine growth restriction (IUGR).
  • To understand why maternal asthma increases allergy risk in offspring.

Main Methods:

  • Utilizing ovine models to experimentally induce intrauterine growth restriction (IUGR).
  • Administering methyl donor supplementation to pregnant ewes.
  • Analyzing immune responses in progeny, including cutaneous responses and IgE levels.
  • Examining fetal thymus immune populations during maternal asthma exacerbations in sheep and assessing allergy development in progeny of asthmatic mice.

Main Results:

  • Experimental IUGR in sheep reduced progeny's cutaneous allergic responses, despite normal or high IgE.
  • Maternal methyl donor supplementation partially reversed IUGR effects, suggesting epigenetic involvement.
  • Ovine experimental allergic asthma affected fetal size and thymus immune cell activation.
  • Maternal asthma in mice predisposed offspring to allergy.

Conclusions:

  • A perturbed prenatal environment directly alters immune system development and postnatal function.
  • Epigenetic pathways may mediate some effects of IUGR on allergic susceptibility.
  • Experimental models provide valuable insights into mechanisms underlying prenatal influences on allergy and potential interventions.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
Allergic Reactions02:06

Allergic Reactions

Overview
32.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.0K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.0K